As specialty therapies grow more complex and patient expectations continue to rise, life sciences organizations are under increasing pressure to deliver patient support programs (PSPs) that are faster, more accurate and built to scale. Traditional, labor-heavy approaches that once helped “move patients through the system” are no longer sufficient in a market where both patients and healthcare providers (HCPs) expect immediacy, transparency and minimal friction.
Today, life sciences organizations are rethinking how access, affordability and adherence solutions are designed — and how technology and data must work together to support speed to therapy without sacrificing accuracy or patient experience.
The End of Manual, One-Size-Fits-All Access Models
Across the industry, life sciences organizations are recognizing a fundamental shift: reliance on manual workarounds and volume-based staffing to manage access is no longer sustainable. Programs built primarily on talent-enabled workflows struggle to scale, adapt to product lifecycle changes or withstand disruptions — whether those disruptions stem from vendor outages, payer complexity or changing portfolios.
Now, organizations are seeking solutions that can:
- Scale efficiently as products mature and patient volumes fluctuate
- Maintain continuity when systems, vendors or market conditions change
- Deliver accurate, real-time data to inform operational and strategic decisions
- Reduce friction for patients, HCPs and pharmacies
At the same time, patient expectations continue to be shaped by seamless digital experiences in everyday life. While patient support is not a consumer retail experience, patients and HCPs increasingly expect clarity, speed and minimal delays — not fragmented handoffs or extended wait times. This shift is pushing life sciences organizations to modernize access models with efficiency and reliability at the core.
Designing PSPs Around Access, Affordability and Adherence
Also at the center of effective PSPs are three tightly connected pillars: access, affordability and adherence. Optimizing one without the others introduces gaps that can negatively impact outcomes.
Access: Speed to therapy begins with clear, accurate access decisions. AssistRx Advanced eServices play a critical role in helping life sciences organizations understand a patient’s coverage and remove barriers such as prior authorizations, step edits and administrative delays.
Our Advanced Benefit Verification (ABV) solutions provide real-time visibility into both pharmacy and medical benefits, down to the product level and specific administration requirements. Coverage insights are presented directly to HCPs within their workflows, reducing uncertainty and eliminating unnecessary back-and-forth.
From there, Advanced Prior Authorization (APA) enables near real-time payer responses through direct integrations, allowing decisions to be made in minutes instead of days or weeks. This streamlined approach improves data accuracy, reduces missing information and accelerates patient movement through the access journey.
Affordability: As therapies progress through different lifecycle stages, affordability strategies must evolve alongside them. Tech-enabled affordability solutions help determine not only what coverage exists, but how to route patients to the most appropriate pathway — whether that includes copay assistance, free drug programs or alternative dispensing options.
Digitized enrollment and intelligent triage ensure patients can move quickly to the next step without manual delays, while scalable infrastructure allows programs to adapt as volume and complexity increase.
Adherence: Initiating therapy is only the beginning. Long-term success depends on sustained engagement, education and support throughout the patient journey.
AssistRx incorporates artificial intelligence (AI) to enhance experiences and improve program performance. Through AI-driven targeting and next best action capabilities, predictive intelligence helps optimize and personalize interactions — increasing therapy initiation, supporting sustained adherence and enabling timely, relevant interventions throughout the patient journey.
Technology-enabled adherence solutions, such as our Advanced Clinical Education (ACE) solution, provide direct connections between patients and clinicians for injection training, disease-state education and ongoing guidance. These tools help patients understand their therapy requirements and next steps, reinforcing confidence and continuity while supporting long-term adherence.
Meeting Patients and HCPs Where They Are
One of the most significant evolutions in patient support design is the shift toward meeting stakeholders within their existing environments — rather than requiring them to adapt to new systems or workflows.
For HCPs, this means access and affordability insights delivered directly within EHRs. For patients, it means support embedded into real-life moments — including the pharmacy counter — where decisions and actions occur quickly. For pharmacies, it means cleaner data and faster processing at the point of dispense.
AssistRx’s Advanced Access Anywhere (AAA) solution was built with this reality in mind. By enabling access services to initiate at the point of prescription and the point of dispense, AAA eliminates enrollment forms, improves data quality and accelerates speed to therapy. Patients can move from clinical decision to medication access in days — or even hours — instead of weeks, without changing established behaviors for HCPs or pharmacies.
Questions to Ask When Evaluating a Patient Support Partner
When assessing patient support solutions, life sciences organizations should consider asking:
- How is technology being used to drive efficiency and scalability — and where does manual effort still exist?
- What mechanisms are in place to ensure the program can scale across product lifecycle stages and fluctuating patient volumes?
- How is program data delivered, who has access to it, and how are insights shared across internal stakeholders?
- What investments are being made to continuously improve innovation, redundancy and long-term program resilience?
- How does the solution support emerging models, such as direct-to-patient engagement, while maintaining compliance and data integrity?
Explore the Right Balance of Tech + Talent
As specialty therapies continue to grow and diversify, PSPs must be designed for flexibility, resilience and speed. Life sciences organizations that invest in scalable, integrated access solutions today are better positioned to adapt to changes in the market.
Connect with our team today to explore how innovative access solutions like AAA can help your organization accelerate therapy access, strengthen program resilience and improve outcomes across the patient journey.